1887

Abstract

LL-37, the only human cathelicidin, is a cationic antimicrobial peptide with antibacterial and antifungal activity. LL-37 is released from neutrophil granules and produced by epithelial cells. It has been implicated in host defence against influenza A virus (IAV) in recent studies. We now demonstrate dose-related neutralizing activity of LL-37 against several seasonal and mouse-adapted IAV strains. The ability of LL-37 to inhibit these IAV strains resulted mainly from direct effects on the virus, since pre-incubation of virus with LL-37 was needed for optimal inhibition. LL-37 bound high-density lipoprotein (HDL), and pre-incubation of LL-37 with human serum or HDL reduced its antiviral activity. LL-37 did not inhibit viral association with epithelial cells as assessed by quantitative RT-PCR or confocal microscopy. This finding contrasted with results obtained with surfactant protein D (SP-D). Unlike collectins or human neutrophil defensins (HNPs), LL-37 did not induce viral aggregation under electron microscopy. In the electron microscopy studies, LL-37 appeared to cause disruption of viral membranes. LL-37 had additive antiviral activity when combined with other innate inhibitors like SP-D, surfactant protein A and HNPs. Unlike HNPs, LL-37 did not bind SP-D significantly. These findings indicate that LL-37 contributes to host defence against IAV through a mechanism distinct from that of SP-D and HNPs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.045013-0
2013-01-01
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/1/40.html?itemId=/content/journal/jgv/10.1099/vir.0.045013-0&mimeType=html&fmt=ahah

References

  1. Barlow P. G. , Svoboda P. , Mackellar A. , Nash A. A. , York I. A. , Pohl J. , Davidson D. J. , Donis R. O. . ( 2011; ). Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. . PLoS ONE 6:, e25333. [CrossRef] [PubMed]
    [Google Scholar]
  2. Bergman P. , Walter-Jallow L. , Broliden K. , Agerberth B. , Söderlund J. . ( 2007; ). The antimicrobial peptide LL-37 inhibits HIV-1 replication. . Curr HIV Res 5:, 410–415. [CrossRef] [PubMed]
    [Google Scholar]
  3. Braff M. H. , Jones A. L. , Skerrett S. J. , Rubens C. E. . ( 2007; ). Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis. . J Infect Dis 195:, 1365–1372. [CrossRef] [PubMed]
    [Google Scholar]
  4. Burton M. F. , Steel P. G. . ( 2009; ). The chemistry and biology of LL-37. . Nat Prod Rep 26:, 1572–1584. [CrossRef] [PubMed]
    [Google Scholar]
  5. Caverly J. M. , Diamond G. , Gallup J. M. , Brogden K. A. , Dixon R. A. , Ackermann M. R. . ( 2003; ). Coordinated expression of tracheal antimicrobial peptide and inflammatory-response elements in the lungs of neonatal calves with acute bacterial pneumonia. . Infect Immun 71:, 2950–2955. [CrossRef] [PubMed]
    [Google Scholar]
  6. Chromek M. , Slamová Z. , Bergman P. , Kovács L. , Podracká L. , Ehrén I. , Hökfelt T. , Gudmundsson G. H. , Gallo R. L. . & other authors ( 2006; ). The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. . Nat Med 12:, 636–641. [CrossRef] [PubMed]
    [Google Scholar]
  7. Crouch E. , Nikolaidis N. , McCormack F. X. , McDonald B. , Allen K. , Rynkiewicz M. J. , Cafarella T. M. , White M. , Lewnard K. . & other authors ( 2011; ). Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo. . J Biol Chem 286:, 40681–40692. [CrossRef] [PubMed]
    [Google Scholar]
  8. Doss M. , White M. R. , Tecle T. , Gantz D. , Crouch E. C. , Jung G. , Ruchala P. , Waring A. J. , Lehrer R. I. , Hartshorn K. L. . ( 2009; ). Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. . J Immunol 182:, 7878–7887. [CrossRef] [PubMed]
    [Google Scholar]
  9. Doss M. , White M. R. , Tecle T. , Hartshorn K. L. . ( 2010; ). Human defensins and LL-37 in mucosal immunity. . J Leukoc Biol 87:, 79–92. [CrossRef] [PubMed]
    [Google Scholar]
  10. Gaudreault E. , Gosselin J. . ( 2008; ). Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice. . J Immunol 180:, 6211–6221.[PubMed] [CrossRef]
    [Google Scholar]
  11. Gaynor C. D. , McCormack F. X. , Voelker D. R. , McGowan S. E. , Schlesinger L. S. . ( 1995; ). Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. . J Immunol 155:, 5343–5351.[PubMed]
    [Google Scholar]
  12. Hansdottir S. , Monick M. M. , Hinde S. L. , Lovan N. , Look D. C. , Hunninghake G. W. . ( 2008; ). Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. . J Immunol 181:, 7090–7099.[PubMed] [CrossRef]
    [Google Scholar]
  13. Hartshorn K. L. . ( 2010; ). Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense. . Front Biosci (Schol Ed) 2:, 527–546. [CrossRef] [PubMed]
    [Google Scholar]
  14. Hartshorn K. L. , Collamer M. , Auerbach M. , Myers J. B. , Pavlotsky N. , Tauber A. I. . ( 1988; ). Effects of influenza A virus on human neutrophil calcium metabolism. . J Immunol 141:, 1295–1301.[PubMed]
    [Google Scholar]
  15. Hartshorn K. L. , Crouch E. C. , White M. R. , Eggleton P. , Tauber A. I. , Chang D. , Sastry K. . ( 1994; ). Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. . J Clin Invest 94:, 311–319. [CrossRef] [PubMed]
    [Google Scholar]
  16. Hartshorn K. , Chang D. , Rust K. , White M. , Heuser J. , Crouch E. . ( 1996; ). Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. . Am J Physiol 271:, L753–L762.[PubMed]
    [Google Scholar]
  17. Hartshorn K. L. , Sastry K. N. , Chang D. , White M. R. , Crouch E. C. . ( 2000a; ). Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein. . Am J Physiol Lung Cell Mol Physiol 278:, L90–L98.[PubMed]
    [Google Scholar]
  18. Hartshorn K. L. , White M. R. , Voelker D. R. , Coburn J. , Zaner K. , Crouch E. C. . ( 2000b; ). Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. . Biochem J 351:, 449–458. [CrossRef] [PubMed]
    [Google Scholar]
  19. Hartshorn K. L. , White M. R. , Tecle T. , Holmskov U. , Crouch E. C. . ( 2006; ). Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. . J Immunol 176:, 6962–6972.[PubMed] [CrossRef]
    [Google Scholar]
  20. Hashimoto Y. , Moki T. , Takizawa T. , Shiratsuchi A. , Nakanishi Y. . ( 2007; ). Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. . J Immunol 178:, 2448–2457.[PubMed] [CrossRef]
    [Google Scholar]
  21. Lai Y. , Gallo R. L. . ( 2009; ). AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. . Trends Immunol 30:, 131–141. [CrossRef] [PubMed]
    [Google Scholar]
  22. Larrick J. W. , Morgan J. G. , Palings I. , Hirata M. , Yen M. H. . ( 1991; ). Complementary DNA sequence of rabbit CAP18 – a unique lipopolysaccharide binding protein. . Biochem Biophys Res Commun 179:, 170–175. [CrossRef] [PubMed]
    [Google Scholar]
  23. Lau Y. E. , Bowdish D. M. , Cosseau C. , Hancock R. E. , Davidson D. J. . ( 2006; ). Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. . Am J Respir Cell Mol Biol 34:, 399–409. [CrossRef] [PubMed]
    [Google Scholar]
  24. Liu P. T. , Stenger S. , Li H. , Wenzel L. , Tan B. H. , Krutzik S. R. , Ochoa M. T. , Schauber J. , Wu K. . & other authors ( 2006; ). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. . Science 311:, 1770–1773. [CrossRef] [PubMed]
    [Google Scholar]
  25. Liu P. T. , Stenger S. , Tang D. H. , Modlin R. L. . ( 2007; ). Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. . J Immunol 179:, 2060–2063.[PubMed] [CrossRef]
    [Google Scholar]
  26. Oppenheim J. J. , Yang D. . ( 2005; ). Alarmins: chemotactic activators of immune responses. . Curr Opin Immunol 17:, 359–365. [CrossRef] [PubMed]
    [Google Scholar]
  27. Salvatore M. , Garcia-Sastre A. , Ruchala P. , Lehrer R. I. , Chang T. , Klotman M. E. . ( 2007; ). α-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). . J Infect Dis 196:, 835–843. [CrossRef] [PubMed]
    [Google Scholar]
  28. Smee D. F. , Bailey K. W. , Wong M. H. , O’Keefe B. R. , Gustafson K. R. , Mishin V. P. , Gubareva L. V. . ( 2008; ). Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N. . Antiviral Res 80:, 266–271. [CrossRef] [PubMed]
    [Google Scholar]
  29. Sørensen O. E. , Follin P. , Johnsen A. H. , Calafat J. , Tjabringa G. S. , Hiemstra P. S. , Borregaard N. . ( 2001; ). Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. . Blood 97:, 3951–3959. [CrossRef] [PubMed]
    [Google Scholar]
  30. Tate M. D. , Deng Y. M. , Jones J. E. , Anderson G. P. , Brooks A. G. , Reading P. C. . ( 2009; ). Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. . J Immunol 183:, 7441–7450. [CrossRef] [PubMed]
    [Google Scholar]
  31. Tecle T. , White M. R. , Gantz D. , Crouch E. C. , Hartshorn K. L. . ( 2007; ). Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. . J Immunol 178:, 8046–8052.[PubMed] [CrossRef]
    [Google Scholar]
  32. Tjabringa G. S. , Aarbiou J. , Ninaber D. K. , Drijfhout J. W. , Sørensen O. E. , Borregaard N. , Rabe K. F. , Hiemstra P. S. . ( 2003; ). The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. . J Immunol 171:, 6690–6696.[PubMed] [CrossRef]
    [Google Scholar]
  33. White M. R. , Doss M. , Boland P. , Tecle T. , Hartshorn K. L. . ( 2008; ). Innate immunity to influenza virus: implications for future therapy. . Expert Rev Clin Immunol 4:, 497–514. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.045013-0
Loading
/content/journal/jgv/10.1099/vir.0.045013-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error